VOYA Investment Management’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$156K Buy
15,624
+4,940
+46% +$37.5K ﹤0.01% 2288
2026
Q1
$76.9K Sell
10,684
-476
-4% -$3.06K ﹤0.01% 2226
2025
Q4
$62.9K Hold
11,160
﹤0.01% 2317
2025
Q3
$68.9K Sell
11,160
-7,088
-39% -$41.4K ﹤0.01% 2352
2025
Q2
$88.9K Buy
+18,248
New +$64.5K ﹤0.01% 2512
2022
Q2
Sell
-1,558
Closed -$28K 2878
2022
Q1
$28K Hold
1,558
﹤0.01% 2634
2021
Q4
$41K Sell
1,558
-46
-3% -$1.41K ﹤0.01% 2757
2021
Q3
$57K Hold
1,604
﹤0.01% 2794
2021
Q2
$88K Buy
1,604
+727
+83% +$48K ﹤0.01% 2786
2021
Q1
$73K Buy
877
+98
+13% +$10.8K ﹤0.01% 2712
2020
Q4
$89K Buy
+779
New +$49.3K ﹤0.01% 2578
2020
Q2
Sell
-755
Closed -$27K 2608
2020
Q1
$27K Hold
755
﹤0.01% 2569
2019
Q4
$50K Buy
+755
New +$83.3K ﹤0.01% 2640
2018
Q4
Sell
-318
Closed -$225K 2579
2018
Q3
$225K Buy
+318
New +$200K ﹤0.01% 2281

Other funds holding SLDB

VOYA Investment Management's SLDB Position: Q2 2026 in Review

VOYA Investment Management increased its Solid Biosciences (SLDB) stake by 46% in Q2 2026, buying an estimated $37.5K and bringing the position to 15,624 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

VOYA Investment Management first reported a position in SLDB in Q3 2018 and has held it in 14 quarters since. The position peaked at $225K in Q3 2018. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • VOYA Investment Management held 15,624 shares of Solid Biosciences worth $156K as of Q2 2026.
  • VOYA Investment Management bought 4,940 Solid Biosciences shares in Q2 2026, an estimated $37.5K.
  • Solid Biosciences made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2288 holding.
  • VOYA Investment Management first reported a position in Solid Biosciences in Q3 2018 and has held it in 14 quarters since.
  • VOYA Investment Management's Solid Biosciences position peaked at $225K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.